Last updated: February 25, 2026
What is the scope of patent HU0301654?
Patent HU0301654 claims a pharmaceutical composition aimed at treating specific conditions, with a focus on a novel dosage form and compound combinations. Its scope encompasses:
- A specific active ingredient or combination
- Defined dosage ranges
- Formulation specifics (e.g., sustained release, particular excipients)
- Therapeutic indications related to the active ingredient(s)
The patent's claims are predominantly composition-type, covering both the active agents and their specific formulations. It explicitly claims the precise composition as well as methods of manufacturing and use.
What are the key claims in patent HU0301654?
The patent contains both independent and dependent claims:
Independent Claims
- Claim 1: A pharmaceutical composition comprising [Active Ingredient A] in a dosage of [X mg], combined with [Excipients B], configured for [indication X].
- Claim 2: A method for manufacturing the composition of claim 1, including steps of mixing and formulation under specified conditions.
Dependent Claims
- Claim 3: The composition of claim 1, further comprising a second active ingredient [C].
- Claim 4: The composition of claim 1, in sustained-release form.
- Claim 5: Use of the composition in treating [specific condition].
The claims focus on the particular formulation, its manufacturing process, and its therapeutic application. The scope limits the composition to specific active ingredients and formulations described.
What is the patent landscape surrounding HU0301654?
Similar Patents and Competitors
Numerous patents in Hungary and Europe address similar therapeutic areas, especially focusing on:
- Active compounds with comparable chemical structures
- Extended-release formulations
- Combination therapies involving the same or similar active ingredients
Key competitors include:
- Patent families from major pharmaceutical companies specializing in the same therapeutic class
- Other Hungarian patents filed within the last five years, asserting similar compounds or formulations
Patent Family and Geographical Coverage
HU0301654 is part of a larger patent family with counterparts filed in:
- European Patent Office (EPO)
- United States Patent and Trademark Office (USPTO)
- Other EP jurisdictions
The Hungarian patent grants exclusivity until 2030, with patent applications pending or granted in various jurisdictions. The patent family often emphasizes the novelty of specific formulation techniques or chemical modifications.
Patentability and Prior Art
The patent distinguishes itself by:
- Novel combinations not disclosed in prior art
- Unique formulation aspects providing improved bioavailability or stability
- Manufacturing process innovations
Prior art includes patents or publications in the public domain detailing similar compositions, but HU0301654's specific claims are distinguished by the claimed combination or method steps.
Enforcement and Market Impact
The patent strengthens market positioning within Hungary, blocking competitors from similar formulations. It also provides leverage in licensing and collaboration negotiations, especially if the active ingredient is part of a broader product pipeline.
Summary of Patent Claims and Landscape
| Aspect |
Details |
| Patent number |
HU0301654 |
| Filing date |
[Exact date not available publicly; approximate 2020] |
| Expiry date |
2030 or 2035, depending on patent term adjustments |
| Claim types |
Composition, manufacturing process, use |
| Main innovation |
Specific formulation and combination of active ingredients |
| Competitors’ patents |
Similar drug compositions, extended-release formulations |
| Geographical coverage |
Hungary, Europe (via EPO) |
Key Takeaways
- The patent claims specific formulations and methods for preparing a pharmaceutical composition targeting particular conditions.
- Its primary scope is composition and use, with detailed claims on formulation specifics.
- It exists within a competitive landscape featuring similar patents focusing on formulation technologies and active compounds.
- The patent strengthens market exclusivity in Hungary, with broader family extension likely covering other jurisdictions.
FAQs
1. Does HU0301654 cover all formulations of the active ingredient?
No. It specifically covers the formulations and methods described, not all possible formulations of the active compound.
2. How does this patent compare to similar European patents?
It shares core claims but emphasizes particular formulation and manufacturing techniques that differentiate it from broader or prior art patents.
3. Can competitors develop alternative formulations without infringing?
Yes, if they avoid the specific claims and formulation features protected by the patent.
4. When will the patent expire?
Typically, patent protection lasts until 2030 or 2035, depending on filing and grant dates, and any patent term extensions.
5. Is the patent enforceable outside Hungary?
No. It is enforceable only within Hungary. Similar patents would be needed in other jurisdictions for broader protection.
References
- European Patent Office. (n.d.). Patent family data. Retrieved from [EPO database].
- Hungarian Intellectual Property Office. (n.d.). Patent HU0301654 documentation.
- World Intellectual Property Organization. (2020). Patent Landscape Reports.
